Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography,  and the nuclear imaging modalities of PET and SPECT. 

RSS icon
Thumbnail

Molecular imaging’s might

Molecular imaging has made an impact in a diverse number of clinical arenas. No longer the new technology on the block, it has continued to flex its might in neuroimaging, cardiovascular imaging and oncology through a number of important research projects in 2012.

ASBD: MDs should share breast density, cancer risk info with women

Women need to understand breast density and its impact on lifetime breast cancer risk, according to a statement issued by the American Society of Breast Disease (ASBD).

Musculoskeletal Imaging in the Era of Molecular Medicine

Nov. 30, 8:30-10:00 a.m. | S504CD | This session delves into molecular imaging for musculoskeletal malignancies and developments for imaging musculoskeletal pain. Learn the rationale for using molecular imaging in the musculoskeletal system and get up to speed on the latest orthopedic research.

FDG/PET-based Cancer Treatment Response Assessment

Nov. 28, 8:30-10:00 a.m. | S504CD | This session examines important PET/CT findings using FDG and other tracers. Participants also learn how to avoid potential pitfalls, use PET tracers to evaluate tumor response and compare available tracer options for evaluating treatment response.

Essentials of Molecular Imaging and Systems Diagnostics for Clinical Radiologists

Nov. 27, 4:30-6:00 p.m. | S504CD | Brush up on the basics of molecular imaging and how it’s used in practice with this session. Speakers explore the latest in radiogenomics and molecular theranostics.

Molecular Imaging of the Breast

Nov. 27, 8:30-10:00 a.m. | E353A | This session is designed to help participants sort through the different technologies and detector configurations available for molecular imaging of the breast and also demonstrates the potential for the technology in both diagnostic and screening environments.

Cardiovascular Imaging in the Era of Molecular Medicine

Nov. 27, 8:30-10:00 a.m. | S504CD | This session focuses on the clinical role that molecular imaging could play in the management of cardiovascular disease. Molecular imaging application in atherosclerosis, myocardial infarction, thrombosis syndromes and cardiac transplant rejection are discussed, followed by a panel discussion on the future of the technology.

Molecular and Functional Imaging/Surrogate Markers in Radiation Oncology

Nov. 26, 8:30-10:00 a.m. | S504AB | Learn about the potential of functional and molecular imaging before and after cytotoxic therapy in this session. It also covers the role of imaging as a predictor of tumor control and survival.

Displaying 6153 - 6160 of 23559

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.